1996
DOI: 10.1016/0041-0101(96)00017-7
|View full text |Cite
|
Sign up to set email alerts
|

Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
96
0
32

Year Published

1998
1998
2007
2007

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 208 publications
(130 citation statements)
references
References 77 publications
2
96
0
32
Order By: Relevance
“…Three PIII SVMPs, jararhagin from B. jararaca venom, atrolysin A from C. atrox venom, and kaouthiagin from Naja kaouthia venom, have been demonstrated to bind and/or proteolytically cleave VWF (9,10,32). In the case of kaouthiagin, the site of cleavage in VWF was identified at Pro 708 -Asp 709 in the C-terminal hinge region of the VWA1 domain (32).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Three PIII SVMPs, jararhagin from B. jararaca venom, atrolysin A from C. atrox venom, and kaouthiagin from Naja kaouthia venom, have been demonstrated to bind and/or proteolytically cleave VWF (9,10,32). In the case of kaouthiagin, the site of cleavage in VWF was identified at Pro 708 -Asp 709 in the C-terminal hinge region of the VWA1 domain (32).…”
Section: Discussionmentioning
confidence: 99%
“…The PIII SVMP jararhagin has been demonstrated to bind to and cleave VWF and the integrin ␣2␤1 (9). In both cases binding to these proteins resulted in proteolytic cleavage of the protein.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In jararhagin-treated platelets, no alterations of gpIb could be detected either by flow cytometry or by immunoprecipitation (44). This indicated that jararhagin inhibition of platelet responses to the ristocetin/ vWF complex may have been due to some effect on the multimeric plasma protein, vWF.…”
Section: Venom MDC Enzymes and Platelet Functionmentioning
confidence: 66%
“…The 225-kDa vWF subunit contains the Val 449 -Lys 728 N-terminal domain responsible for ristocetin-induced binding to platelet gpIb, and one binding site for platelet α IIb ß 3 integrin containing the C-terminal RGDS 1744-1747 sequence (45). We have shown that the treatment of vWF with jararhagin resulted in the proteolysis of vWF subunits in the N-terminal half of the molecule which contains the platelet gpIb binding site (44). Thus, jararhagin inhibited platelet responses to ristocetin by cleaving the ligand vWF, with loss of the gpIb binding site.…”
Section: Venom MDC Enzymes and Platelet Functionmentioning
confidence: 99%